|Hospital outbreak of Middle East respiratory syndrome coronavirus|
A Assiri, A McGeer, TM Perl, CS Price, AA Al Rabeeah, DAT Cummings, ...
New England Journal of Medicine 369 (5), 407-416, 2013
|Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase|
MH St. Clair, JL Martin, G Tudor-Williams, MC Bach, CL Vavro, DM King, ...
Science 253 (5027), 1557-1559, 1991
|Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma|
N Dupin, C Fisher, P Kellam, S Ariad, M Tulliez, N Franck, E Van Marck, ...
Proceedings of the National Academy of Sciences 96 (8), 4546-4551, 1999
|HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma|
N Dupin, TL Diss, P Kellam, M Tulliez, MQ Du, D Sicard, RA Weiss, ...
Blood, The Journal of the American Society of Hematology 95 (4), 1406-1412, 2000
|IFITM3 restricts the morbidity and mortality associated with influenza|
AR Everitt, S Clare, T Pertel, SP John, RS Wash, SE Smith, CR Chin, ...
Nature 484 (7395), 519-523, 2012
|The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells|
SA Radkov, P Kellam, C Boshoff
Nature medicine 6 (10), 1121-1127, 2000
|Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.|
P Kellam, CA Boucher, BA Larder
Proceedings of the National Academy of Sciences 89 (5), 1934-1938, 1992
|LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration|
MC Shun, NK Raghavendra, N Vandegraaff, JE Daigle, S Hughes, ...
Genes & development 21 (14), 1767-1778, 2007
|Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects|
CAB Boucher, E O'Sullivan, JW Mulder, C Ramautarsing, P Kellam, ...
Journal of Infectious Diseases 165 (1), 105-110, 1992
|Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays|
RG Jenner, MM Alba, C Boshoff, P Kellam
Journal of virology 75 (2), 891-902, 2001
|Poxvirus genomes: a phylogenetic analysis|
C Gubser, S Hué, P Kellam, GL Smith
Journal of General Virology 85 (1), 105-117, 2004
|Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013|
ZA Memish, M Cotten, B Meyer, SJ Watson, AJ Alsahafi, AA Al Rabeeah, ...
Emerging infectious diseases 20 (6), 1012, 2014
|Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study|
M Cotten, SJ Watson, P Kellam, AA Al-Rabeeah, HQ Makhdoom, A Assiri, ...
The Lancet 382 (9909), 1993-2002, 2013
|Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes|
BA Larder, P Kellam, SD Kemp
Aids 5 (2), 137-144, 1991
|Virus genomes reveal factors that spread and sustained the Ebola epidemic|
G Dudas, LM Carvalho, T Bedford, AJ Tatem, G Baele, NR Faria, DJ Park, ...
Nature 544 (7650), 309-315, 2017
|The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection|
P Kellam, W Barclay
The Journal of general virology 101 (8), 791, 2020
|Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals|
YH Zhang, Y Zhao, N Li, YC Peng, E Giannoulatou, RH Jin, HP Yan, ...
Nature communications 4 (1), 1-6, 2013
|Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus|
M Cotten, SJ Watson, AI Zumla, HQ Makhdoom, AL Palser, SH Ong, ...
MBio 5 (1), e01062-13, 2014
|Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2|
AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ...
Cell 183 (5), 1367-1382. e17, 2020
|Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates|
P Kellam, BA Larder
Antimicrobial agents and chemotherapy 38 (1), 23-30, 1994